Department of Obstetrics and Gynecology, Mount Sinai Hospital, University of Toronto, Ontario, Canada.
J Multidiscip Healthc. 2011;4:233-7. doi: 10.2147/JMDH.S21401. Epub 2011 Jul 22.
Overactive bladder (OAB) is a prevalent and persistent condition that is often under-diagnosed and under-treated, and which frequently requires tailored treatment for successful management.
This consensus opinion-based review summarizes the discussions of a group of experts in the field of OAB that were assembled to evaluate the importance of correct diagnosis and appropriate pharmacotherapy in patients with OAB.
A thorough diagnostic process is crucial for allowing exclusion of underlying medical issues and differentiation from genitourinary conditions other than OAB. In addition, selecting the most appropriate pharmacotherapy needs to be carefully considered in the context of each patient with OAB. In general, patients with OAB tend to be older with various comorbidities and often receiving multiple concomitant medications. Treatment decisions should take into consideration the differing potential for antimuscarinic medications to alter cognitive and cardiovascular functions, both of which may be compromised in this patient population.
Tailoring treatment to individual patients by comprehensive patient assessment may lead to more effective management of patients with OAB, especially those receiving polypharmacy for comorbidities.
膀胱过度活动症(OAB)是一种常见且持续存在的病症,常被漏诊和治疗不足,且通常需要针对特定患者进行个体化治疗才能成功管理。
本基于共识的综述总结了一组 OAB 领域专家的讨论,这些专家聚集在一起评估正确诊断和适当药物治疗在 OAB 患者中的重要性。
彻底的诊断过程对于排除潜在的医学问题和区分 OAB 以外的泌尿生殖系统疾病至关重要。此外,需要根据每位 OAB 患者的具体情况仔细考虑选择最合适的药物治疗。一般来说,OAB 患者年龄较大,合并多种疾病,经常同时服用多种药物。治疗决策应考虑到抗毒蕈碱药物改变认知和心血管功能的潜力差异,而这两种功能在该患者人群中可能受到损害。
通过全面的患者评估为每位患者量身定制治疗方案可能会导致 OAB 患者的管理更加有效,特别是那些因合并症而接受多种药物治疗的患者。